Sumitomo Dainippon Pharma (Japan)

2.1k papers and 55.5k indexed citations i.

About

In recent decades, authors affiliated with Sumitomo Dainippon Pharma (Japan) have published 2.1k papers, which have received a total of 55.5k indexed citations. Scholars at this organization have produced 787 papers in Molecular Biology, 328 papers in Cellular and Molecular Neuroscience and 287 papers in Organic Chemistry on the topics of Neuroscience and Neuropharmacology Research (170 papers), Receptor Mechanisms and Signaling (116 papers) and Antibiotics Pharmacokinetics and Efficacy (95 papers). Their work is cited by papers focused on Molecular Biology (22.3k citations), Cellular and Molecular Neuroscience (7.9k citations) and Pharmacology (5.6k citations). Authors at Sumitomo Dainippon Pharma (Japan) collaborate with scholars in Japan, United States and United Kingdom and have published in prestigious journals including New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society. Some of Sumitomo Dainippon Pharma (Japan)'s most productive authors include Shinichi Nakamura, Hisahiro Yoshida, Takahiro Ochiya, Fumitaka Takeshita, Haruhisa Iguchi, Yusuke Yoshioka, Nobuyoshi Kosaka, M Bogaki, Mami Nakamura and Yasushi Matsuki.

In The Last Decade

Fields of papers published by authors at Sumitomo Dainippon Pharma (Japan)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Sumitomo Dainippon Pharma (Japan) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Sumitomo Dainippon Pharma (Japan) at the time of their publication.

Countries citing scholars working at Sumitomo Dainippon Pharma (Japan)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Sumitomo Dainippon Pharma (Japan). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Sumitomo Dainippon Pharma (Japan) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumitomo Dainippon Pharma (Japan) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025